Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-03-09 4:17 pm Purchase | 13G | Cepton, Inc. CPTN | Point72 Asset Management L.P. | 1,815,228 1.2% | 1,815,228 (New Position) | View |
| 2023-02-23 7:43 pm Purchase | 13G | Inari Medical, Inc. NARI | Point72 Asset Management L.P. | 2,795,352 5.2% | 2,795,352 (New Position) | View |
| 2023-02-17 4:35 pm Purchase | 13G | Iovance Biotherapeutics, Inc. IOVA | Point72 Asset Management L.P. | 8,114,890 5% | 8,114,890 (New Position) | View |
| 2023-02-14 4:27 pm Purchase | 13G | Prometheus Biosciences, Inc. RXDX | Point72 Asset Management L.P. | 3,114,107 6.7% | 1,131,546 (+57.07%) | View |
| 2023-02-14 4:25 pm Purchase | 13G | Marinus Pharmaceuticals, Inc. MRNS | Point72 Asset Management L.P. | 3,515,356 7.1% | 116,695 (+3.43%) | View |
| 2023-02-14 4:23 pm Purchase | 13G | Gritstone bio, Inc. GRTS | Point72 Asset Management L.P. | 7,702,831 9.2% | 1,094,273 (+16.56%) | View |
| 2023-02-14 4:23 pm Sale | 13G | Cidara Therapeutics, Inc. CDTX | Point72 Asset Management L.P. | 3,868,006 5.4% | -450,034 (-10.42%) | View |
| 2023-02-14 4:22 pm Purchase | 13G | FibroGen, Inc. FGEN | Point72 Asset Management L.P. | 6,281,645 6.7% | 1,615,538 (+34.62%) | View |
| 2023-02-14 4:22 pm Sale | 13G | Avalo Therapeutics, Inc. AVTX | Point72 Asset Management L.P. | 500,737 5.3% | -5,511,939 (-91.67%) | View |
| 2023-02-14 4:21 pm Sale | 13G | AnaptysBio, Inc. ANAB | Point72 Asset Management L.P. | 2,124,200 7.5% | -157,000 (-6.88%) | View |
| 2023-02-14 4:20 pm Purchase | 13G | Abeona Therapeutics Inc. ABEO | Point72 Asset Management L.P. | 1,150,648 7.4% | 189,778 (+19.75%) | View |
| 2023-02-14 4:20 pm Purchase | 13G | Eos Energy Enterprises, Inc. EOSE | Point72 Asset Management L.P. | 5,535,030 6.7% | 2,493,265 (+81.97%) | View |
| 2023-02-14 4:19 pm Sale | 13G | IDEAYA Biosciences, Inc. IDYA | Point72 Asset Management L.P. | 69,450 0.1% | -1,984,767 (-96.62%) | View |
| 2023-02-14 4:19 pm Sale | 13G | Xenon Pharmaceuticals Inc. XENE | Point72 Asset Management L.P. | 1,178,501 1.9% | -1,828,637 (-60.81%) | View |
| 2023-02-14 4:18 pm Sale | 13G | Health Catalyst, Inc. HCAT | Point72 Asset Management L.P. | 1,920,253 3.5% | -864,631 (-31.05%) | View |
| 2023-02-14 4:18 pm Sale | 13G | X4 Pharmaceuticals, Inc. XFOR | Point72 Asset Management L.P. | 913,242 1.3% | -719,962 (-44.08%) | View |
| 2023-02-14 4:17 pm Unchanged | 13G | Cepton, Inc. CPTN | Point72 Asset Management L.P. | 0 0% | 0 (Unchanged) | View |
| 2023-02-14 4:17 pm Sale | 13G | uniQure N.V. QURE | Point72 Asset Management L.P. | 1,745,461 3.7% | -1,866,230 (-51.67%) | View |
| 2023-02-14 4:16 pm Sale | 13G | Tricida, Inc. TCDA | Point72 Asset Management L.P. | 167,509 0.3% | -3,117,394 (-94.90%) | View |
| 2023-02-14 4:15 pm Sale | 13G | Fulcrum Therapeutics, Inc. FULC | Point72 Asset Management L.P. | 30,702 0.1% | -2,037,172 (-98.52%) | View |